Related Experiment Video
Updated: Aug 8, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
Nitric oxide in children with persistent asthma
Nulma S Jentzsch1, Muriel le Bourgeois, Jacques de Blic
1Faculdade de Ciências Médicas de Minas Gerais, Belo Horizonte, MG, Brasil.
Insights
Exhaled nitric oxide levels are higher in atopic asthma patients, indicating underlying inflammation despite clinical stability. This suggests atopic asthma may require closer monitoring for inflammation control.
Area of Science:
- Pediatric Allergy and Immunology
- Respiratory Medicine
- Clinical Diagnostics
Background:
- Asthma management often relies on clinical symptoms and lung function tests.
- Atopic individuals exhibit heightened immune responses, potentially influencing asthma severity and treatment response.
- Exhaled nitric oxide (FeNO) is a non-invasive biomarker of airway inflammation.
Purpose of the Study:
- To compare exhaled nitric oxide (FeNO) levels between atopic and non-atopic asthmatic children on anti-inflammatory drugs.
- To evaluate the correlation between FeNO measurements and standard lung function tests in pediatric asthma.
Main Methods:
- A cross-sectional study involving 45 children (6-17 years) with persistent asthma on anti-inflammatory therapy.
- Patients were categorized into atopic (positive skin tests) and non-atopic groups.
- Concomitant assessment of clinical symptoms, lung function (FEV1, FEV1/FVC, FEF25-75%), and FeNO levels.
Main Results:
- Atopic patients showed significantly higher FeNO levels (p < 0.001) and a higher frequency of eczema (p < 0.005).
- No significant differences were observed in asthma symptoms, allergic rhinitis, food allergy, or need for systemic corticosteroids between groups.
- Lung function parameters (FEV1, FEV1/FVC, FEF25-75%) did not significantly differ between atopic and non-atopic asthmatic children.
Conclusions:
- Elevated FeNO in atopic asthmatic children suggests persistent airway inflammation not fully captured by clinical or lung function assessments.
- Clinical and functional stability in atopic asthma may mask underlying inflammation, potentially increasing relapse risk after therapy cessation.
- FeNO measurement offers valuable insights into airway inflammation in pediatric asthma, complementing traditional diagnostic tools.
Objective:
To assess the difference in exhaled nitric oxide levels in atopic and nonatopic asthmatic patients treated with anti-inflammatory drugs, and to compare exhaled nitric oxide measurement with lung function tests.
Methods:
Cross-sectional study with 45 consecutively selected patients with moderate and severe persistent asthma, aged between 6 and 17 years, and treated with anti-inflammatory drugs for at least 1 year. The patients were split into two groups: atopic ones (with positive skin tests) and nonatopic ones. The clinical and functional assessments and the measurement of exhaled nitric oxide were carried out concomitantly.
Results:
There was a male predominance (62.5%), with an age range between 6 and 13 years (mean of 10.4 years) in 85% of the patients. Neither the symptoms associated with asthma (p = 0.07), allergic rhinitis (p = 0.17), food allergy (p = 0.09), necessity of systemic corticosteroids (p = 0.10), antileukotrienes (p = 0.20) and antihistamines (p = 0.70), nor the three parameters used to assess lung function (FEV(1), FEV(1)/FVC and FEF(25-75%), p > or = 0.14) were statistically significant. The frequency of eczema (p < 0.005) and exhaled nitric oxide levels (p < 0.001) were higher among atopic patients.
Conclusion:
Results suggest that clinical and functional stability of asthma among atopic patients does not necessarily reflect an efficient control over the inflammatory process and a higher probability for recurrence after discontinuation of anti-inflammatory therapy.
Related Concept Videos
Nitric Oxide Signaling Pathway
Asthma III: Clinical Manifestations
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
